OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
March 24, 2023
Amid continued tussling over drug costs, a new working group will review the government’s authority to revoke licenses for medical products.
March 14, 2023
Pending FDA approval, agreement expected to support once-daily stimulant medication.
March 13, 2023
Silicon Valley Bank has collapsed, leaving many biotechnology companies unsure of the future.
March 10, 2023
Manufacturer to withdraw preterm birth drug, amid latest FDA push.
March 07, 2023
Latest investigation signals more scrutiny of pharmacy benefit managers and their role in treatment cost and coverage.
February 03, 2023
The platform is designed to reduce barriers to care for patients with COVID-19.
January 13, 2023
In its ninth year, the survey includes the opinions of over 240 US-based patient groups on the performance of the pharmaceutical industry in 2021.
The HBA announced the 2023 Woman of the Year, Honorable Mentor, and STAR recipients.
January 12, 2023
The report highlights various treatments for HIV, Parkinson's disease, Crohn's disease, alopecia, multiple myeloma, and breast cancer.
December 15, 2022
The FDA tapped the Reagan-Udall Foundation to launch the initiative.